These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2839630)

  • 1. The role of plasma angiotensin I converting enzyme in regulation of renin-angiotensin system activity in patients with essential hypertension.
    Ishida H; Shimamoto K; Ando T; Nishitani T; Hosoda S; Yokoyama T; Fukuyama S; Mori Y; Nakagawa H; Ogata H
    J Clin Hypertens; 1987 Dec; 3(4):681-4. PubMed ID: 2839630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma renin activity and changes in tissue angiotensin converting enzyme.
    Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL
    J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z; Feng H; Leng X; Ma F; Wang B; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heritability of plasma renin activity and plasma concentration of angiotensinogen and angiotensin-converting enzyme.
    Vinck WJ; Fagard RH; Vlietinck R; Lijnen P
    J Hum Hypertens; 2002 Jun; 16(6):417-22. PubMed ID: 12037697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelation between the renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension.
    Ishida H; Shimamoto K; Nishitani T; Hosoda S; Yokoyama T; Nakahashi Y; Ando T; Tanaka S; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():329-36. PubMed ID: 3028077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
    Jiang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme and metals in untreated essential hypertension.
    Ekmekci OB; Donma O; Tunckale A
    Biol Trace Elem Res; 2003 Dec; 95(3):203-10. PubMed ID: 14665725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of angiotensin-converting enzyme inhibitor, foroxymithine, on dynamic equilibrium around the renin-angiotensin system in vivo.
    Aoyagi T; Wada T; Iinuma H; Ogawa K; Kojima F; Nagai M; Kuroda H; Obayashi A; Umezawa H
    J Appl Biochem; 1985 Dec; 7(6):388-95. PubMed ID: 3007425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
    Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
    Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
    Martyniuk TV; Chazova IE; Masenko VP; Volkov VN; Belenkov IuN
    Ter Arkh; 1998; 70(4):33-6. PubMed ID: 9612899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chronic prazosin therapy on the response of the renin-angiotensin system in patients with essential hypertension.
    Webb DJ; Fulton JD; Leckie BJ; Malatino LS; McAreavey D; Morton JJ; Murray GD; Robertson JI
    J Hum Hypertens; 1987 Dec; 1(3):195-200. PubMed ID: 3506626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
    Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The behavior of serum angiotensin-converting enzyme in normotensive subjects, in subjects with essential hypertension and in subjects with primary hyperaldosteronism on the orthostatic test].
    Letizia C; Cerci S; De Ciocchis A; Tarsitani P; D'Ambrosio C; Coassin S; Scavo D
    Minerva Cardioangiol; 1992 Dec; 40(12):505-11. PubMed ID: 1338343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.